ARCHITECT 2K45-20Recalls & reported problems
Abbott Laboratories · ARCHITECT CA125 II Reagent Kit · Class 2
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380740003388), received between Jul 10, 2019 and Jul 10, 2019 — classified as 1 injury.
The most frequently reported specific device problem is “High Test Results” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- High Test Results1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJul 10, 2019High Test Results; High Test Results
THE CUSTOMER REPORTED A (B)(6) FEMALE PATIENT UNDERWENT A CAT SCAN WITH IV CONTRAST, AN ENTEROSCOPY, AND A GASTROSCOPY BASED ON FALSELY ELEVATED CA 19-9 AND CA125 RESULTS GENERATED ON THE ARCHITECT I2000SR ANALYZER. RESULTS PROVIDED: SID (B)(6), (B)(6) 2019 CA 19-9 = >1200 U/ML / REFERENCE LAB = <37 U/ML; SID (B)(6), (B)(6) 2019 CA125 = 126.4 U/ML / REFERENCE LAB = <35 U/ML. THE PATIENT IS DOING WELL AND THERE WAS NO ADVERSE IMPACT TO THE PATIENTS HEALTH REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8776748 ↗
Other TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125) devices
- ADVIA Centaur® CA 125II 10310443Siemens Healthcare Diagnostics Inc. · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)1 recall10 reports
- ADVIA Centaur® CA 125 II 10315696Siemens Healthcare Diagnostics Inc. · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)1 recall0 reports
- ARCHITECT 02K4529Abbott GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)8 reports
- Atellica IM CA 125II 10995482Siemens Healthcare Diagnostics Inc. · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)3 reports
- ARCHITECT 02K4539Abbott GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)3 reports
- Elecsys CA 125 II Assay 11776223161Roche Diagnostics GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)2 reports
- Alinity 08P4920Abbott GmbH · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)2 reports
- IMMULITE® 2000 Systems OV OM-MA (CA125) 10380972Siemens Healthcare Diagnostics Products Ltd · TEST, EPITHELIAL OVARIAN TUMOR-ASSOCIATED ANTIGEN (CA125)2 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.